Morgan Stanley Neuro Sense Therapeutics Ltd. Transaction History
Morgan Stanley
- $1.23 Trillion
- Q1 2024
A detailed history of Morgan Stanley transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Morgan Stanley holds 1,500 shares of NRSN stock, worth $1,275. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$1,275
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding NRSN
# of Institutions
9Shares Held
167KCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny71.1KShares$60,4350.0% of portfolio
-
Meitav Dash Investments LTD50KShares$42,5000.0% of portfolio
-
Woodline Partners LP San Francisco, CA19.6KShares$16,6430.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$10,1680.0% of portfolio
-
Ubs Group Ag11.9KShares$10,1380.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $9.92M